Back to 
Quadrature Capital Ltd
Quadrature Capital Ltd
NGEN1 quarters
Position history for Quadrature Capital Ltd's holdings in NERVGEN PHARMA CORP
Yes. Quadrature Capital holds 134,518 shares of NGEN (Nervgen Pharma), worth $277,107, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$277,107
Current Shares
134,518
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of NGEN: LMR Partners LLP, MARSHALL WACE, LLP, UBS Group AG, BANK OF AMERICA CORP /DE/